Medical imaging has been an established part of the clinical arsenal for over 30 years. Instrumental and technological developments continue to be the main driving force behind research aimed at better establishing the presence or severity of disease, and assessing response to treatment using more relevant clinical and preclinical information.
The aim of RE2 is to develop and promote specific approaches and advances to enable breakthroughs in each imaging modality. Beyond these individual challenges, developments combining two or more modalities open up radically new perspectives in diagnosis and therapy, with enhanced sensitivity and specificity.